Oral Nicotine Pouches Versus Nicotine Replacement Therapy to Reduce Cigarette Use for Smokers in Rural Appalachia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorOhio State University Comprehensive Cancer Center

About this trial

This clinical trial compares the use of oral nicotine pouches to nicotine replacement therapy, consisting of nicotine patches and lozenges, to reduce cigarette use in smokers living in rural Appalachia. The lung and oral cancers that plague Appalachia are fueled by cigarette smoking. Oral nicotine pouches which contain nicotine but no tobacco leaf, present a new opportunity to reduce cancer risk among Appalachian adults who smoke. Oral nicotine pouches and nicotine replacement therapy may work well to reduce cigarette use for smokers in rural Appalachia.

Eligibility criteria

Qualifiers

Read and speak English

21 years or older

Smoke ≥ 5 cigarettes per day for the past year

Willing to use Oral Nicotine Pouches (ONP) or Nicotine Replacement Therapy (NRT)

Disqualifiers

Report currently using smoking cessation medications, NRT, or actively seeking treatment for smoking cessation

Use of ONPs in past 3 months

Use of Nicotine Replacement Therapies in past 3 months

Use of other tobacco products > 10 days/month

Trial design

Treatments tested in this trial

  • Carbon Monoxide Measurement
  • Nicotine Lozenge
  • Oral Nicotine Pouch
  • Nicotine Patch
  • Survey Administration
  • Check-in Phone Calls

Treatment groups

1,000 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ohio State University Comprehensive Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator